Microdosing Tirzepatide Starting at $585.00 Tirzepatide Starting at $399.00 Semaglutide Starting at $299.00 Glutathione injections Starting at $45.00 Nutrient Injections Starting at $25.00 PT-141 Starting at $199.00 Methylene Blue Starting at $99.00 Metformin Starting at $49.00 Sermorelin Starting at $249.00 IV Therapy Starting at $350.00 NAD+ Wafers Starting at $100.00 TRT with Enclomiphene Starting at $289.00 FBHRT Starting at $289.00 GLP-1 + GIP Starting at $399.00 GLP-1 Starting at $299.00 NAD+ Injections Starting at $249.00 Our five core pillars target the root causes of weight gain and metabolic dysfunction to help you lose weight sustainably, feel energized, and transform your health for life
The Mediterranean diet and health: a comprehensive overview (2021) Journal of Internal Medicine
*Correspondence: Jonathan D
Sermorelin and other GHRH analogs compete for the same receptors, making combination unnecessary
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound) in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity, as an adjunct to diet and physical activity
GLP-1S is a synthetic receptor agonist widely used in preclinical research to investigate glucose-dependent insulin secretion, modulation of gastric emptying, regulation of appetite pathways, and beta-cell function in metabolic models
